Atom | PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

Due Dates: September 5, 2025 (New, Renewal, Resubmission, Revision)

Funding Amounts: Phase I: up to $306,872 (1 year) | Phase II: up to $2,045,816 (2 years); higher budgets possible for select topics

Summary: Supports U.S. small businesses to conduct R&D and clinical trials aligned with NIH research missions through the STTR program.

Key Information: Clinical trial(s) are required; only U.S. small businesses are eligible; updated program priorities as of March 2025.

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)